CoreTissue BioEngineering Inc.
Developing Artificial Ligament for
Knee Anterior Cruciate Ligament Reconstruction
▶ March 18, 2021 CTBE obtained the manufacturing and marketing authorization of the highly controlled medical devices.
▶Dec. 25, 2020 AMED adopted CTBE to the Grant, "the 5th CiCLE: Cyclic Innovation for Clinical Empowerment 2020"
▶ Aug. 7, 2020 CoreTissue BioEngineering and Teijin Limited agree on alliance to mass produce artificial ligament
▶ July 7, 2020 The annual report of the AMED grant program was published - Japanese only
▶June 18, 2020 The CEO went onto the online platform of the Joint Pitch - Deep Tech for Good: Medical Innovations
sponsored by SGInnovate (Singapore) and Japan Science and Technology Agency (JST) More Details
▶ Feb. 12, 2020. The 2020 renewal of the AMED grant program was approved - Japanese only
▶ Nov. 26, 2019 The CEO went onto the platform of the 34th NEDO Pitch "Academic Venture x Health-tech" - Japanese only
▶ Nov. 18, 2019 Received grant from the Ogasawara Foundation for the Promotion of Science & Engineering.
▶ Oct. 16, 2019 Funded as the first investment by Waseda University Official Fund - Japanese only